retatrutide benefits clinical trial Perceived of treatment for obesity with retatrutide: A qualitative study of patients in a phase 2 Retatrutide Significantly Reduces Visceral Fat
Description
This can slow or reverse fatty liver disease, which is common in people with obesity
From a morbidity and lifeinsurance perspective, those shifts could be positive, pointing to improvements in weight, blood sugar and cardiovascular risk over time
Our goal is results that hold not a rebound cycle
Coverage varies by carrier and state, so this should be confirmed before a program goes live
